Identification of Predictive Biomarkers

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

April 5, 2023

Study Completion Date

April 5, 2023

Conditions
Prostate Cancer Recurrent
Interventions
OTHER

Blood sample

"Additional blood sample of about 30 ml that will be drawn for biomarker analyses (2 EDTA = ethylenediaminetetraacetic acid and 1 Cell-search-tubes).The drawn blood for CTC-Analysis and biomarker identification will be promptly processed ac-cording to the established standards at the Institute for Tumor Biology (see below).~The histological analysis of the resected tissue during salvage surgery is carried out according to clinical routine (conventional haematoxylin and eosin stained and PSMA-Immunohistochemistry). Additionally, tissue samples will undergo molecularpathological analysis if this does not affect routine pathological examination."

Trial Locations (1)

20246

Martini-Klinik am UKE GmbH, Hamburg

All Listed Sponsors
collaborator

Erich und Gertrud Roggenbuck-Stiftung zur Förderung der Krebsforschung

UNKNOWN

lead

Martini-Klinik am UKE GmbH

OTHER

NCT04324983 - Identification of Predictive Biomarkers | Biotech Hunter | Biotech Hunter